跳至主要内容
临床试验/NCT01262170
NCT01262170已完成1 期

A Randomized, Double-Blind, Active-Controlled, Crossover, Pilot Study to Evaluate the Safety and Efficacy of CigRx™ Lozenge, a Non-Nicotine Non-Tobacco Dietary Supplement, in Daily Smokers in Temporarily Reducing the Desire to Smoke

Rock Creek Pharmaceuticals, Inc.1 个研究点 分布在 1 个国家目标入组 109 人开始时间: 2010年4月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
109
试验地点
1
主要终点
Effect on subject's craving to smoke

研究概览

简要总结

A randomized, double-blind, active-controlled, crossover, pilot study to evaluate the safety and efficacy of CigRx™ Lozenge, a dietary supplement, in daily smokers in temporarily reducing the desire to smoke

详细描述

Subjects will orally self-administer 2 study products, each in the form of a dissolvable lozenge, and will complete questionnaires on demographics, urges to smoke, and product rating.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
23 Years 至 72 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Healthy adult smokers
  • •Smoking for at least 5 years
  • •Smoking at least one (1) pack of cigarettes a day

排除标准

  • •Allergy to lozenge components

研究组 & 干预措施

CigRx Lozenge

Experimental

CigRx Lozenge

干预措施: CigRx Lozenge (Dietary Supplement)

Tobacco Lozenge

Active Comparator

Tobacco Lozenge

干预措施: Tobacco Lozenge (Other)

结局指标

主要结局

Effect on subject's craving to smoke

时间窗: 4 hours

craving is assessed by changes in questionnaire answers over time

次要结局

  • Collection of information on adverse events related to study products(5 hours)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验